{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T20:23:59Z","timestamp":1770150239695,"version":"3.49.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2012,11,21]],"date-time":"2012-11-21T00:00:00Z","timestamp":1353456000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1007\/s10875-012-9837-2","type":"journal-article","created":{"date-parts":[[2012,11,22]],"date-time":"2012-11-22T16:43:54Z","timestamp":1353602634000},"page":"666-670","source":"Crossref","is-referenced-by-count":23,"title":["Increased Plasma Interleukin-32 Expression in Patients with Neuromyelitis Optica"],"prefix":"10.1007","volume":"33","author":[{"given":"Honghao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conghui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fangcheng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueqiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,11,21]]},"reference":[{"key":"9837_CR1","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1016\/S0140-6736(04)17551-X","volume":"364","author":"VA Lennon","year":"2004","unstructured":"Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Na-kashima I, Weinshenker BG. A serum auto-antibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106\u201312.","journal-title":"Lancet."},{"key":"9837_CR2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s10875-012-9709-9","volume":"32","author":"H Wang","year":"2012","unstructured":"Wang H, Wang K, Zhong X, Qiu W, Dai Y, Wu A, Hu X. Cerebrospinal fluid BAFF and APRIL levels in neuromyelitis optica and multiple sclerosis patients during relapse. J Clin Immunol. 2012;32:1007\u201311.","journal-title":"J Clin Immunol."},{"key":"9837_CR3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S1474-4422(12)70133-3","volume":"11","author":"MC Papadopoulos","year":"2012","unstructured":"Papadopoulos MC, Verkman AS. Aquaporin 4 and neuromyelitis optica. Lancet Neurol. 2012;11:535\u201344.","journal-title":"Lancet Neurol."},{"key":"9837_CR4","first-page":"51450","volume":"12","author":"CF Lucchinetti","year":"2002","unstructured":"Lucchinetti CF, Mandler RN, McGavern D, Bruck W, Gleich G, Ransohoff RM, Trebst C, Weinshenker B, Wingerchuk D, Parisi JE, Lassmann H. A role for humoral mechanisms in the pathogenesis of Devic's neuromyelitis optica. Brain. 2002;12:51450\u20131461.","journal-title":"Brain."},{"key":"9837_CR5","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/WCO.0b013e3283533a3f","volume":"25","author":"MH Barnett","year":"2012","unstructured":"Barnett MH, Sutton I. Neuromyelitis optica: not a multiple sclerosis variant. Curr Opin Neurol. 2012;25:215\u201320.","journal-title":"Curr Opin Neurol."},{"key":"9837_CR6","doi-asserted-by":"crossref","first-page":"7127","DOI":"10.4049\/jimmunol.1002306","volume":"186","author":"E Turner-Brannen","year":"2011","unstructured":"Turner-Brannen E, Choi KY, Arsenault R, El-Gabalawy H, Napper S, Mookherjee N. Inflammatory cytokines IL-32 and IL-17 have common signaling intermediates despite differential dependence on TNF-receptor 1. J Immunol. 2011;186:7127\u201335.","journal-title":"J Immunol."},{"key":"9837_CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1023\/A:1011020225433","volume":"21","author":"L Steinman","year":"2001","unstructured":"Steinman L, Conlon P. Antigen specific immunotherapy of multiple sclerosis. J Clin Immunol. 2001;21:93\u20138.","journal-title":"J Clin Immunol."},{"key":"9837_CR8","doi-asserted-by":"crossref","unstructured":"Park YE, Kim GT, Lee SG, Park SH, Baek SH, Kim SI, Kim JI, Jin HS. IL-32 aggravates synovial inflammation and bone destruction and increases synovial natural killer cells in experimental arthritis models. Rheumatol Int. 2012;PubMed PMID: 22527134.","DOI":"10.1007\/s00296-012-2385-5"},{"key":"9837_CR9","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.jaci.2011.12.1002","volume":"129","author":"N Meyer","year":"2012","unstructured":"Meyer N, Christoph J, Makrinioti H, Indermitte P, Rhyner C, Soyka M, Eiwegger T, Chalubinski M, Wanke K, Fujita H, Wawrzyniak P, B\u00fcrgler S, Zhang S, Akdis M, Menz G, Akdis C. Inhibition of angiogenesis by IL-32: possible role in asthma. J Allergy Clin Immunol. 2012;129:964\u201373.","journal-title":"J Allergy Clin Immunol."},{"key":"9837_CR10","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1007\/s00415-011-6036-7","volume":"258","author":"SJ Na","year":"2011","unstructured":"Na SJ, So SH, Lee KO, Choi YC. Elevated serum level of interleukin-32\u03b1 in the patients with myasthenia gravis. J Neurol. 2011;258:1865\u201370.","journal-title":"J Neurol."},{"key":"9837_CR11","doi-asserted-by":"crossref","unstructured":"Heinhuis B, Netea MG, van den Berg WB, Dinarello CA, Joosten LA. Interleukin-32: A predominantly intracellular proinflammatory mediator that controls cell activation and cell death. Cytokine. 2012;PubMed PMID: 22878344.","DOI":"10.1016\/j.cyto.2012.07.010"},{"key":"9837_CR12","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.4049\/jimmunol.1003996","volume":"186","author":"MY Jung","year":"2011","unstructured":"Jung MY, Son MH, Kim SH, Cho D, Kim TS. IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production. J Immunol. 2011;186:6848\u201359.","journal-title":"J Immunol."},{"key":"9837_CR13","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2174\/187152812800959022","volume":"11","author":"J Noh","year":"2012","unstructured":"Noh J, Noh G. Allergen-specific. Responses of CD19high and CD19low B Cells in Non-IgE mediated food allergy of late eczematous reactions in atopic dermatitis: presence of IL-17- and IL-32-producing regulatory B cells (Br17 & Br32). Inflamm Allergy Drug Targets. 2012;11:320\u20139.","journal-title":"Inflamm Allergy Drug Targets."},{"key":"9837_CR14","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006;66:1485\u20139.","journal-title":"Neurology."},{"key":"9837_CR15","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Fujihara K, Havrdova E, Hutchinson M, Kappos L, Lublin FD, Montalban X, O'Connor P, Sandberg-Wollheim M, Thompson AJ, Waubant E, Weinshenker B, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69:292\u2013302.","journal-title":"Ann Neurol."},{"key":"9837_CR16","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/ard.2010.139196","volume":"70","author":"B Heinhuis","year":"2011","unstructured":"Heinhuis B, Koenders MI, van Riel PL, van de Loo FA, Dinarello CA, Netea MG, van den Berg WB, Joosten LA. Tumour necrosis factor alpha-driven IL-32 expression in rheumatoid arthritis synovial tissue amplifies an inflammatory cascade. Ann Rheum Dis. 2011;70:660\u20137.","journal-title":"Ann Rheum Dis."},{"key":"9837_CR17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.jinf.2012.05.009","volume":"65","author":"Q Xu","year":"2012","unstructured":"Xu Q, Pan X, Shu X, Cao H, Li X, Zhang K, Lu J, Zou Y, Li X, Liu H, Zhang Y, Yang D, Ning Q, Shen G, Li G. Increased interleukin-32 expression in chronic hepatitis B virus-infected liver. J Infect. 2012;65:336\u201342.","journal-title":"J Infect."},{"key":"9837_CR18","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1074\/jbc.M111.288290","volume":"287","author":"B Heinhuis","year":"2012","unstructured":"Heinhuis B, Koenders MI, van den Berg WB, Netea MG, Dinarello CA, Joosten LA. Interleukin 32 (IL-32) contains a typical \u03b1-helix bundle structure that resembles focal adhesion targeting region of focal adhesion kinase-1. J Biol Chem. 2012;287:5733\u201343.","journal-title":"J Biol Chem."},{"key":"9837_CR19","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.autrev.2006.08.015","volume":"6","author":"P Conti","year":"2007","unstructured":"Conti P, Youinou P, Theoharides TC. Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32). Autoimmun Rev. 2007;6:131\u20137.","journal-title":"Autoimmun Rev."},{"key":"9837_CR20","doi-asserted-by":"crossref","first-page":"16309","DOI":"10.1073\/pnas.0508237102","volume":"102","author":"MG Netea","year":"2005","unstructured":"Netea MG, Azam T, Ferwerda G, Girardin SE, Walsh M, Park JS, Abraham E, Kim JM, Yoon DY, Dinarello CA, Kim SH. IL-32 synergizes with nucleotide oligomerization domain (NOD) 1 and NOD2 ligands for IL-1beta and IL-6 production through a caspase 1-dependent mechanism. Proc Natl Acad Sci U S A. 2005;102:16309\u201314.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"9837_CR21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1159\/000339302","volume":"19","author":"H Wang","year":"2012","unstructured":"Wang H, Wang K, Zhong X, Dai Y, Qiu W, Wu A, Hu X. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica. Neuroimmunomodulation. 2012;19:304\u20138.","journal-title":"Neuroimmunomodulation."},{"key":"9837_CR22","doi-asserted-by":"crossref","first-page":"3701","DOI":"10.1073\/pnas.1017385108","volume":"108","author":"N Chihara","year":"2011","unstructured":"Chihara N, Aranami T, Sato W, Miyazaki Y, Miyake S, Okamoto T, Ogawa M, Toda T, Yamamura T. Interleukin 6 signaling promotes anti-aquaporin 4 autoantibody production from plasmablasts in neuromyelitis optica. Proc Natl Acad Sci U S A. 2011;108:3701\u20136.","journal-title":"Proc Natl Acad Sci U S A."},{"key":"9837_CR23","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.4049\/jimmunol.163.5.2403","volume":"163","author":"R Furlan","year":"1999","unstructured":"Furlan R, Martino G, Galbiati F, Poliani PL, Smiroldo S, Bergami A, Desina G, Comi G, Flavell R, Su MS, Adorini L. Caspase-1 regulates the inflammatory process leading to autoimmune demyelination. J Immunol. 1999;163:2403\u20139.","journal-title":"J Immunol."},{"key":"9837_CR24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.it.2011.02.007","volume":"32","author":"J Zepp","year":"2011","unstructured":"Zepp J, Wu L, Li X. IL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease. Trends Immunol. 2011;32:232\u20139.","journal-title":"Trends Immunol."},{"key":"9837_CR25","first-page":"525","volume":"64","author":"T Misu","year":"2012","unstructured":"Misu T, Takahashi T, Nakashima I, Fujihara K. Biomarkers in neuromyelitis optica. Brain Nerve. 2012;64:525\u201335.","journal-title":"Brain Nerve."},{"key":"9837_CR26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/ana.23651","volume":"72","author":"M Varrin-Doyer","year":"2012","unstructured":"Varrin-Doyer M, Spencer CM, Schulze-Topphoff U, Nelson PA, Stroud RM, Cree BA, Zamvil SS. Aquaporin 4-specific T cells in neuromyelitis optica exhibit a Th17 bias and recognize Clostridium ABC transporter. Ann Neurol. 2012;72:53\u201364.","journal-title":"Ann Neurol."},{"key":"9837_CR27","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.jocn.2011.01.031","volume":"18","author":"H Wang","year":"2011","unstructured":"Wang H, Dai Y, Qiu W, Lu Z, Peng F, Wang Y, Bao J, Li Y, Hu X. Interleukin-17-secreting T cells in neuromyelitis optica and multiple sclerosis during relapse. J Clin Neurosci. 2011;18:1313\u20137.","journal-title":"J Clin Neurosci."},{"key":"9837_CR28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jneuroim.2011.03.009","volume":"234","author":"Y Li","year":"2011","unstructured":"Li Y, Wang H, Long Y, Lu Z, Hu X. Increased memory Th17 cells in patients with neuromyelitis optica and multiple sclerosis. J Neuroimmunol. 2011;234:155\u201360.","journal-title":"J Neuroimmunol."}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9837-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10875-012-9837-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-012-9837-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T23:22:10Z","timestamp":1687821730000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10875-012-9837-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,21]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["9837"],"URL":"https:\/\/doi.org\/10.1007\/s10875-012-9837-2","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,21]]}}}